Concepedia

Kathryn Vanderlaag

KV

Statistics

Publications

5

Citations

261

H-Index

5

Active since

2006

Affiliations

Texas A&M University(Current)

Texas A&M Health Science Center

Kathryn Vanderlaag is an author at Texas A&M University specializing in oncology, cancer cell signaling, and molecular oncology.

Publications per year

2006–2011

5

Publications

5

Anterior gradient-2 plays a critical role in breast cancer cell growth and survival by modulating cyclin D1, estrogen receptor-α and survivin

Kathryn Vanderlaag, S Hudak, Laura Bald et al. · Breast Cancer Research · 2010 · 129 citations · Full text

Medicine, Cancer Biology, Oncology +15

Vascular Endothelial Growth Factor Receptor-2 Expression Is Induced by 17β-Estradiol in ZR-75 Breast Cancer Cells by Estrogen Receptor α/Sp Proteins

Kelly J. Higgins, Shengxi Liu, Maen Abdelrahim et al. · Endocrinology · 2006 · 53 citations

Life Sciences, Molecular Biology, Oncology +17

Vascular Endothelial Growth Factor Receptor-2 Expression Is Down-Regulated by 17β-Estradiol in MCF-7 Breast Cancer Cells by Estrogen Receptor α/Sp Proteins

Kelly J. Higgins, Shengxi Liu, Maen Abdelrahim et al. · Molecular Endocrinology · 2007 · 38 citations · Full text

Life Sciences, Endocrinology, Molecular Biology +17

1,1-Bis(3'-indolyl)-1-(p-biphenyl)methane inhibits basal-like breast cancer growth in athymic nude mice

Yunpeng Su, Kathryn Vanderlaag, Courtney Ireland et al. · Breast Cancer Research · 2007 · 21 citations · Full text

Medicine, Oncology, Pharmacology +13

Regenerating islet‐derived family member, 4 modulates multiple receptor tyrosine kinases and mediators of drug resistance in cancer

Kathryn Vanderlaag, Wei Wang, Laurence Fayadat‐Dilman et al. · International Journal of Cancer · 2011 · 20 citations · Full text

Medicine, Molecular Biology, Oncology +16

1–5 of 5